Medivation, Inc. (Nasdaq: MDVN) and Astellas Pharma Inc. have established an updated interim analysis plan for the PREVAIL trial, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE